QJM Advance Access first published online on November 28, 2008
This version published online on December 2, 2008
QJM, doi:10.1093/qjmed/hcn158
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
History of the cholesterol controversy in Britain*
From the Department of Metabolic Medicine, Division of Investigative Sciences, Imperial College, Hammersmith Hospital, Ducane Road, London W12 0NN, UK
Address correspondence to Professor G. Thompson, Department of Metabolic Medicine, Division of Investigative Sciences, Imperial College, Hammersmith Hospital, Ducane Road, London W12 0NN. email: g.thompson{at}imperial.ac.uk
| Abstract |
|---|
The lipid hypothesis, the concept that cholesterol plays a causal role in atherosclerosis and cardiovascular disease, has been the subject of a controversy which started in the 1950s, peaked in the 1970s and 80s and then subsided in the 1990s. It was finally resolved by the positive outcome of the Scandinavian Simvastatin Survival Study, the first of 14 prevention trials using statins which showed that lowering cholesterol reduced both cardiovascular events and total mortality. This commentary focuses primarily on the events and people involved in the cholesterol controversy in Britain. The foremost critics of the lipid hypothesis are now deceased but unfortunately for many of the patients with hypercholesterolaemia and coronary heart disease it took the best part of 50 years to disprove the sceptics. This brief account relates why it took so long.
The original version was incorrect. An error to a sentence on page 2 has been amended
*This article is based on the author's book The Cholesterol Controversy (ISBN 978-1-85315-802-5), published by the RSM Press.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. S. Grimes History of the cholesterol hypothesis in Britain QJM, June 1, 2009; 102(6): 436 - 438. [Full Text] [PDF] |
||||
